Skip to main content
Signal8

BioELife Corp. (LITH)

BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

U.S. LITHIUM CORP logo

U.S. LITHIUM CORP

OTC:LITHHealthcare
$0.0001
CLOSED
Mkt Cap$941
EV-
Float6.92M
O/S9.41M
Inst Own-
Net Cash/Sh-
Dilution
Financials Summary
Revenue$0
Net Income-$337K
Total Assets$140K
Free Cash Flow-$77K
Debt & Equity
Total Debt$280K
Total Equity-$325K
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:40Reverse split
    Dec 4, 201840 shares → 1
  2. 1:20Reverse split
    Jul 30, 200320 shares → 1
Balance Sheet Details
Assets$140K
Liabilities$465K
Accounts Receivable$0
Accounts Payable$131K
Inventory$0
PP&E (Net)$15K
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth------------
Cost of Revenue$800$800$0$0$396K$0$0$0$0$0$0$0
Gross Profit-$800-$800-$2K$0-$396K$0$0$0$0$0$0$0
Gross Margin------------
Research and Development$0$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$74K$125K$104K$61K$464K$67K$70K$73K$49K$29K$28K$43K
Other$0$0$0$0$0$0$0$0$0$0$22K$0
Total Operating Expenses$74K$125K$104K$61K$68K$67K$70K$75K$59K$50K$49K$61K
Operating Income (EBIT)-$74K-$125K-$104K-$61K-$464K-$67K$70K-$75K$59K$50K$49K$61K
Operating Margin------------
Interest Expense$83K$122K$106K$39K$35K$18K$15K$11K$7K$2K$0$0
Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$263K-$122K-$106K-$21K-$35K$468-$155K-$11K$0-$2K-$2K$6K
Income Before Tax (EBT)-$337K-$247K-$210K-$82K-$498K-$67K-$85K$0$0$51K$47K$67K
Income Tax Expense$0$0$0$0$0$0$0$86K$125K$103K$99K$122K
Net Income-$337K-$247K-$210K-$82K-$498K-$67K-$85K-$86K-$66K-$52K-$52K-$55K
Net Income Margin------------
Supplementary Data
EPS-0.13-0.10-0.09-0.04-0.44-0.06-0.08-0.08-0.06-0.05-0.05-0.06
Diluted EPS-0.13-0.10-0.09-0.04-0.44-0.06-0.08-0.08-0.06-0.05-0.05-0.06
Weighted Average OS2.61M2.45M2.27M1.89M1.13M1.04M1.04M1.03M1.02M1.02M1.02M990,494
EBITDA-$180K$59-$36-$43K-$464K-$48K-$70K-$75K-$59K-$50K-$47K$61K
EBITDA Margin------------
Balance Sheet
PeriodFY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Assets
Current Assets
Cash and Cash Equivalents$4K$490$8K$1K$256$5K$0$1K$0$3K$581$38K
Short-Term Investments$121K$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$125K$490$8K$1K$256$5K$0$1K$0$3K$581$38K
Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$0$0$9K$0$0$0$0$0$0$0$0$0
Total Current Assets$125K$490$17K$1K$256$5K$0$1K$0$3K$581$38K
Long-Term Assets
Property, Plant & Equipment Net$15K$376K$14K$0$0$0$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Assets$15K$376K$14K$0$0$0$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$140K$377K$31K$1K$256$5K$0$1K$0$3K$581$38K
Liabilities
Current Liabilities
Accounts Payable$131K$114K$83K$68K$59K$42K$46K$36K$19K$0$497$7K
Short-Term Debt$280K$278K$170K$57K$228K$225K$167K$122K$110K$65K$20K$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0$79K$0$10K-$24K-$9K$531$0
Total Current Liabilities$465K$447K$322K$210$353$309K$247K$168$134K$75K$21K$7K
Long-Term Liabilities
Long-Term Debt$0$0$0$10K$16K$436$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$0$0$0$10K$16K$436$0$0$0$0$0$0
Other Liabilities$0$0$0$0$0-$436$0$0$0$0$0$0
Total Liabilities$465K$447K$322K$219K$369K$309K$247K$168K$134K$75K$21K$7K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$1$0$0$0$0$0$0
Common Stock$3K$100K$91K$91K$46K$41K$41K$41K$41K$41K$41K$41K
Retained Earnings-$1.84M-$1.51M-$1.26M-$1.05M-$969K-$470K-$403K-$319K-$233K-$167K-$115K-$63K
Comprehensive Income & Other$0$0$0$0$0$0$0$0$0$0$0$0
Other Stockholders' Equity$1.52M$1.34M$879K$743K$555K$124K$115K$111K$58K$56K$54K$54K
Total Equity-$325K-$71K-$290K-$218K-$368K-$305K-$247K-$166K-$134K-$71K-$20K$31K
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$140K$377K$31K$1K$256$5K$0$1K$0$3K$581$38K
Supplementary Data
Total Debt$280K$278K$170K$67K$244K$225K$21K$122K$110K$65K$20K$0
Net Debt$275K$277K$162K$66K$244$221K$21K$121K$110K$62K$19K-$38K
Cash Flow Statement
PeriodFY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Operating Activities
Net Income-$337K-$247K-$210K-$82K-$498K-$67K-$85K-$86K-$66K-$52K-$52K-$55K
Depreciation & Amortization$74K$125K$104K$0$0$0$0$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$10K$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$28K$33K$15K$0$0$0$0$0$0$0-$6K$3K
  Other Working Capital-$1K-$4K-$25K$39K$24K$8K$0$0$0$0$0$0
Total Working Capital Change$27K$29K-$10K$39K$41K$23K$34K$16K$15K$9K-$6K$3K
Other Non-Cash Items$160K-$29K-$14K$9K$421K-$15K$4K$4K$5K$13K$0$11K
Net Cash from Operating-$76K-$122K-$129K-$33K-$37K-$59K-$47K-$65K-$45K-$31K-$58K-$40K
Investing Activities
Capital Expenditures-$620$0-$4K$0$0$0$0$0-$3K-$11K$0-$5K
Acquisitions$60K$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$266$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$60K$0$0$0$0$0$0$0$0$0$0$0
Net Cash from Investing$60K$0-$4K$0$0$0$0$0-$3K-$11K$0-$5K
Financing Activities
Debt Repaid-$20K-$115K--$10K-$33K-$64K-$5K--$45K-$20K-
Common Stock Issuance$0$0$0$0$0$0$0$50K$0$0$0$4K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$0$0$5K$0-$531$531-$356
Net Cash from Financing$20K$115K$140K$35K$33K$64K$45K$67K$45K$45K$21K$3K
Forex Effect$0$0$0$0$0$0$0$0$0$256$0$0
Net Change in Cash$4K-$7K$6K$1K-$4K$5K-$1K$1K-$3K$3K-$38K-$42K
Supplementary Data
Operating Cash Flow-$76K-$122K-$129K-$33K-$37K-$59K-$47K-$65K-$45K-$31K-$58K-$40K
Capital Expenditure-$620$0-$4K$0$0$0$0$0-$3K-$11K$0-$5K
Free Cash Flow-$77K-$122K-$134K-$33K-$37K-$59K-$47K-$65K-$48K-$42K-$58K-$45K
Cash at Beginning$490$8K$1K$256$5K$0$1K$0$3K$581$38K$80K
Cash at End$4K$490$8K$1K$256$5K$0$1K$0$3K$581$38K